IMPACT STORY 3

Real-World Evidence and Outcome Optimisation

“Can we prove real impact – beyond the clinical trial – in real-world care settings?”

Demonstrating outcomes beyond trials remained a challenge, particularly across diverse patient populations and multiple health systems. A tailored RWE plan was created, implemented through literature reviews, clinician surveys, and large database studies, that integrated pragmatic study design, stakeholder co-creation, and actionable outputs aligned with payer and policy needs.
The Result
This informed HTA evidence and updates, strengthened market access arguments, and reinforced value and uptake across real-world contexts.
Linked Service Line
RWE & Outcome Optimisation
Linked Disease Area
Cross-therapeutic
Linked Product Lifecycle Stage
Early EGP / Post-Launch / On-Market